|
1
|
Błogowski W, Bodnarczuk T and Starzyńska
T: Concise review: Pancreatic cancer and bone marrow-derived stem
cells. Stem Cells Transl Med. 5:938–945. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Assi R, Mukherji D, Haydar A, Saroufim M,
Temraz S and Shamseddine A: Metastatic colorectal cancer presenting
with bone marrow metastasis: A case series and review of
literature. J Gastrointest Oncol. 7:284–297. 2016.PubMed/NCBI
|
|
3
|
Pazionis TJ, Alradwan H, Deheshi BM,
Turcotte R, Farrokhyar F and Ghert M: A systematic review and
meta-analysis of En-Bloc vs. intralesional resection for giant cell
tumor of bone of the distal radius. Open Orthop J. 7:103–108. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maeyama I: Review of bone tumor. Iryo.
24(Suppl): S2271970.(In Japanese).
|
|
5
|
Sanchez-Pareja A, Larousserie F,
Boudabbous S, Beaulieu JY, Mach N, Saiji E and Rougemont AL: Giant
cell tumor of bone with pseudosarcomatous changes leading to
premature denosumab therapy interruption: A case report with review
of the literature. Int J Surg Pathol. 24:366–372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohammadi M, Goudarzi PK, Rahmani O,
Kaghazian P, Yahaghi E, Taheriazam A and Ahmadi K: Evaluation of
gene expression level of CDC5L and MACC1 in poor prognosis and
progression of osteosarcoma. Tumour Biol. 37:8153–8157. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bahador R, Taheriazam A, Mirghasemi A,
Torkaman A, Shakeri M, Yahaghi E and Goudarzi PK: Tissue expression
levels of miR-29b and miR-422a in children, adolescents, and young
adults' age groups and their association with prediction of poor
prognosis in human osteosarcoma. Tumour Biol. 37:3091–3095. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Zhao RH, Tseng KF, Li KP, Lu ZG,
Liu Y, Han K, Gan ZH, Lin SC, Hu HY and Min DL: Sirolimus induces
apoptosis and reverses multidrug resistance in human osteosarcoma
cells in vitro via increasing microRNA-34b expression. Acta
Pharmacol Sin. 37:519–529. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao H, Peng C, Ruan G, Zhou J, Li Y and
Hai Y: Adenovirus-delivered PDCD5 counteracts adriamycin resistance
of osteosarcoma cells through enhancing apoptosis and inhibiting
Pgp. Int J Clin Exp Med. 7:5429–5436. 2014.PubMed/NCBI
|
|
10
|
Tsai HC, Huang CY, Su HL and Tang CH: CCN2
enhances resistance to cisplatin-mediating cell apoptosis in human
osteosarcoma. PLoS One. 9:e901592014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Locklin RM, Federici E, Espina B, Hulley
PA, Russell RG and Edwards CM: Selective targeting of death
receptor 5 circumvents resistance of MG-63 osteosarcoma cells to
TRAIL-induced apoptosis. Mol Cancer Ther. 6:3219–3228. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vourvouhaki E, Carvalho C and Aguiar P:
Model for Osteosarcoma-9 as a potent factor in cell survival and
resistance to apoptosis. Phys Rev E Stat Nonlin Soft Matter Phys.
76:0119262007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH,
Dimri GP, Christensen R, Han T and Park NH: Elevated Bmi-1
expression is associated with dysplastic cell transformation during
oral carcinogenesis and is required for cancer cell replication and
survival. Br J Cancer. 96:126–133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin MX, Wen ZF, Feng ZY and Li ZK:
Association of Bmi-1 expression with clinicopathological features
and prognosis of colorectal cancer. Nan Fang Yi Ke Da Xue Xue Bao.
29:1816–1819. 2009.(In Chinese). PubMed/NCBI
|
|
15
|
Choi YJ, Choi YL, Cho EY, Shin YK, Sung
KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, et al: Expression of
Bmi-1 protein in tumor tissues is associated with favorable
prognosis in breast cancer patients. Breast Cancer Res Treat.
113:83–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raaphorst FM, Meijer CJ and Otte AP:
Correspondence re: S. Beá et al., BMI-1 gene amplification and
overexpression in hematological malignancies occur mainly in mantle
cell lymphomas. Cancer Res. 61:2409–2412, 2001. Cancer Res 62:
618–619. 2002.
|
|
17
|
Li J, Gong LY, Song LB, Jiang LL, Liu LP,
Wu J, Yuan J, Cai JC, He M, Wang L, et al: Oncoprotein Bmi-1
renders apoptotic resistance to glioma cells through activation of
the IKK-nuclear factor-kappaB pathway. Am J Pathol. 176:699–709.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu X, Liu X, Sengupta J, Bu Y, Yi F, Wang
C, Shi Y, Zhu Y, Jiao Q and Song F: Silencing of Bmi-1 gene by RNA
interference enhances sensitivity to doxorubicin in breast cancer
cells. Indian J Exp Biol. 49:105–112. 2011.PubMed/NCBI
|
|
19
|
Jiang L, Wu J, Yang Y, Liu L, Song L, Li J
and Li M: Bmi-1 promotes the aggressiveness of glioma via
activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer.
12:4062012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lai J, Cai Q, Biel MA, Wang C, Hu X, Wang
S and Lin J: Id1 and NF-κB promote the generation of CD133+ and
BMI-1+ keratinocytes and the growth of xenograft tumors in mice.
Int J Oncol. 44:1481–1489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun P, Mu Y and Zhang S: A novel
NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma
promoted by Bmi-1. Tumour Biol. 35:12721–12727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hassanzadeh P: Colorectal cancer and NF-κB
signaling pathway. Gastroenterol Hepatol Bed Bench. 4:127–132.
2011.PubMed/NCBI
|
|
23
|
Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng
Y, Lv J, Song Z, Li Y, Ji L, et al: Shikonin suppresses tumor
growth and synergizes with gemcitabine in a pancreatic cancer
xenograft model: Involvement of NF-κB signaling pathway. Biochem
Pharmacol. 88:322–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Cao CJ, Huang LL, Ke ZF, Luo CJ,
Lin ZW, Wang F, Zhang YQ and Wang LT: EFEMP1 promotes the migration
and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via
NF-κB signaling pathway. Oncotarget. 6:14191–14208. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu LB, Jiang J, Zhu XP, Wang TF, Chen XY,
Luo QF, Shu Y, Liu ZL and Huang SH: Knockdown of Aurora-B inhibits
osteosarcoma cell invasion and migration via modulating
PI3K/Akt/NF-κB signaling pathway. Int J Clin Exp Pathol.
7:3984–3991. 2014.PubMed/NCBI
|
|
26
|
Jamshidi M, Fagerholm R, Khan S, Aittomäki
K, Czene K, Darabi H, Li J, Andrulis IL, Chang-Claude J, Devilee P,
et al: SNP-SNP interaction analysis of NF-κB signaling pathway on
breast cancer survival. Oncotarget. 6:37979–37994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bai FL, Yu YH, Tian H, Ren GP, Wang H,
Zhou B, Han XH, Yu QZ and Li DS: Genetically engineered Newcastle
disease virus expressing interleukin-2 and TNF-related
apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther.
15:1226–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bansal N, Bartucci M, Yusuff S, Davis S,
Flaherty K, Huselid E, Patrizii M, Jones D, Cao L, Sydorenko N, et
al: BMI-1 targeting interferes with patient-derived
tumor-initiating cell survival and tumor growth in prostate cancer.
Clin Cancer Res. 22:6176–6191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen F, Chen L, He H, Huang W, Zhang R, Li
P, Meng Y and Jiang X: Up-regulation of microRNA-16 in glioblastoma
inhibits the function of endothelial cells and tumor angiogenesis
by targeting Bmi-1. Anticancer Agents Med Chem. 16:609–620. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu
LJ, Kong QL, Xu LH, Zhang X, Liu WL, et al: The polycomb group
protein Bmi-1 represses the tumor suppressor PTEN and induces
epithelial-mesenchymal transition in human nasopharyngeal
epithelial cells. J Clin Invest. 119:3626–3636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang MC, Li CL, Cui J, Jiao M, Wu T, Jing
LI and Nan KJ: BMI-1, a promising therapeutic target for human
cancer. Oncol Lett. 10:583–588. 2015.PubMed/NCBI
|
|
34
|
Junan Li, Jye Poi Ming and Ming-Daw Tsai:
The regulatory mechanisms of tumor suppressor P16INK4A
and relevance to cancer. Biochemistry. 50:5566–5582. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu W, Yang Z and Lu N: A new role for the
PI3K/Akt signaling pathway in the epithelial-mesenchymal
transition. Cell Adh Migr. 9:317–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chinchar E, Makey KL, Gibson J, Chen F,
Cole SA, Megason GC, Vijayakumar S, Miele L and Gu JW: Sunitinib
significantly suppresses the proliferation, migration, apoptosis
resistance, tumor angiogenesis and growth of triple-negative breast
cancers but increases breast cancer stem cells. Vasc Cell.
6:122014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guidicelli G, Chaigne-Delalande B,
Dilhuydy MS, Pinson B, Mahfouf W, Pasquet JM, Mahon FX, Pourquier
P, Moreau JF and Legembre P: The necrotic signal induced by
mycophenolic acid overcomes apoptosis-resistance in tumor cells.
PLoS One. 4:e54932009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang JF, Liu Y, Liu WJ and He SY:
Expression of Bmi-1 gene in esophageal carcinoma cell EC9706 and
its effect on cell cycle, apoptosis and migration. Chin J Cancer.
29:689–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu X, Liu Y, Su J, Li D, Hu J, Huang Q, Lu
M, Liu X, Ren J, Chen W and Sun L: Downregulation of Bmi-1 is
associated with suppressed tumorigenesis and induced apoptosis in
CD44 (+) nasopharyngeal carcinoma cancer stem-like cells. Oncol
Rep. 35:923–931. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH,
Band V and Dimri GP: Mel-18 acts as a tumor suppressor by
repressing Bmi-1 expression and down-regulating Akt activity in
breast cancer cells. Cancer Res. 67:5083–5089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Taran K, Wysocka A, Sitkiewicz A, Kobos J
and Andrzejewska E: Evaluation of potential prognostic value of
Bmi-1 gene product and selected markers of proliferation (Ki-67)
and apoptosis (p53) in the neuroblastoma group of tumors. Postepy
Hig Med Dosw (Online). 70:110–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jacobs JJ, Scheijen B, Voncken JW, Kieboom
K, Berns A and van Lohuizen M: Bmi-1 collaborates with c-Myc in
tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
Genes Dev. 13:2678–2690. 1999. View Article : Google Scholar : PubMed/NCBI
|
